Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Acceleron Pharma Inc (XLRN)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Acceleron Pharma Inc.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1280600.
Total stock buying since 2014: $100,246,002.
Total stock sales since 2014: $198,091,133.
Total stock option exercises since 2014: $24,620,985.
Table 3. Detailed insider trading at Acceleron Pharma Inc (XLRN) , Part 3
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2015-01-02 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 5,000 | 1.80 | 9,000 |
| 2014-12-23 | Kania Edwin M Jr (Director) | Sale | 54,350 | 38.00 | 2,065,300 |
| 2014-12-19 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 9,810 | 1.36 | 13,341 |
| 2014-12-19 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 15,000 | 3.88 | 58,200 |
| 2014-12-18 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 5,000 | 40.31 | 201,535 |
| 2014-12-18 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 4,000 | .48 | 1,920 |
| 2014-12-17 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 15,000 | 3.88 | 58,200 |
| 2014-12-17 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 2,000 | 3.88 | 7,760 |
| 2014-12-12 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 4,000 | 41.22 | 164,880 |
| 2014-12-12 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 4,000 | .92 | 3,680 |
| 2014-12-10 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 5,000 | 43.52 | 217,615 |
| 2014-12-10 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 4,000 | 5.08 | 20,320 |
| 2014-12-09 | George Jean (Director) | Sale | 8,778 | 40.11 | 352,085 |
| 2014-12-08 | Maniatis Tom | Sale | 23,400 | 45.00 | 1,053,000 |
| 2014-12-08 | Knopf John L (CEO and President) | Sale | 20,000 | 43.36 | 867,260 |
| 2014-12-08 | George Jean (Director) | Sale | 88,629 | 45.67 | 4,048,129 |
| 2014-12-08 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 10,000 | 43.68 | 436,810 |
| 2014-12-08 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 10,000 | 3.88 | 38,800 |
| 2014-12-01 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 4,000 | 36.14 | 144,548 |
| 2014-12-01 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 4,000 | 5.88 | 23,520 |
| 2014-12-01 | Ertel Steven D (SVP & Chief Business Officer) | Sale | 7,500 | 36.16 | 271,177 |
| 2014-12-01 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 7,500 | 2.60 | 19,500 |
| 2014-11-18 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 5,082 | 34.00 | 172,803 |
| 2014-11-18 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 4,082 | .48 | 1,959 |
| 2014-11-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 4,000 | 33.98 | 135,920 |
| 2014-11-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 4,000 | .92 | 3,680 |
| 2014-11-13 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 12,000 | 35.00 | 420,000 |
| 2014-11-13 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 10,000 | 5.58 | 55,800 |
| 2014-11-12 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 4,000 | 33.01 | 132,040 |
| 2014-11-12 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 4,000 | 5.88 | 23,520 |
| 2014-11-12 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 5,000 | 33.01 | 165,050 |
| 2014-11-12 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 5,000 | 6.50 | 32,500 |
| 2014-11-12 | Ertel Steven D (SVP & Chief Business Officer) | Sale | 10,000 | 33.04 | 330,379 |
| 2014-11-12 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 10,000 | 2.31 | 23,070 |
| 2014-11-12 | Knopf John L (CEO and President) | Sale | 20,000 | 33.07 | 661,400 |
| 2014-11-12 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 4,918 | 33.09 | 162,736 |
| 2014-11-12 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 3,918 | 3.44 | 13,477 |
| 2014-11-12 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 10,000 | 33.00 | 330,030 |
| 2014-11-12 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 10,000 | 3.88 | 38,800 |
| 2014-10-31 | Maniatis Tom | Sale | 23,400 | 40.00 | 936,000 |
| 2014-10-28 | Maniatis Tom | Sale | 17,872 | 35.00 | 625,520 |
| 2014-10-27 | Maniatis Tom | Sale | 5,528 | 35.00 | 193,480 |
| 2014-10-27 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 10,000 | 3.88 | 38,800 |
| 2014-10-20 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 4,918 | 29.11 | 143,162 |
| 2014-10-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 4,000 | 29.02 | 116,080 |
| 2014-10-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 4,000 | .92 | 3,680 |
| 2014-10-08 | Knopf John L (CEO and President) | Sale | 10,000 | 30.20 | 302,000 |
| 2014-10-08 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 5,082 | 29.78 | 151,357 |
| 2014-10-08 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 4,082 | 1.80 | 7,347 |
| 2014-10-07 | Knopf John L (CEO and President) | Sale | 10,000 | 29.22 | 292,200 |
| 2014-10-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 10,000 | 29.25 | 292,500 |
| 2014-10-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 10,000 | 3.88 | 38,800 |
| 2014-10-01 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 4,000 | 29.96 | 119,860 |
| 2014-10-01 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 4,000 | 5.88 | 23,520 |
| 2014-10-01 | Ertel Steven D (SVP & Chief Business Officer) | Sale | 10,000 | 29.90 | 299,030 |
| 2014-10-01 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 10,000 | 2.13 | 21,330 |
| 2014-09-30 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 7,000 | 30.00 | 210,000 |
| 2014-09-30 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 5,000 | 5.58 | 27,900 |
| 2014-09-30 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 7,000 | 30.01 | 210,070 |
| 2014-09-30 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 7,000 | 6.20 | 43,400 |
| 2014-09-18 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 5,000 | 25.48 | 127,425 |
| 2014-09-12 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 2,000 | 25.43 | 50,860 |
| 2014-09-12 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 2,000 | .92 | 1,840 |
| 2014-09-09 | Knopf John L (CEO and President) | Sale | 13,300 | 24.48 | 325,517 |
| 2014-09-09 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 6,700 | 24.50 | 164,116 |
| 2014-09-09 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 6,700 | 3.88 | 25,996 |
| 2014-09-08 | Knopf John L (CEO and President) | Sale | 6,700 | 24.91 | 166,930 |
| 2014-09-08 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 3,300 | 24.90 | 82,170 |
| 2014-09-08 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 3,300 | 3.88 | 12,804 |
| 2014-09-03 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 5,000 | 26.00 | 129,985 |
| 2014-09-03 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 4,000 | 1.80 | 7,200 |
| 2014-09-02 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 2,000 | 26.40 | 52,800 |
| 2014-09-02 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 2,000 | 5.88 | 11,760 |
| 2014-09-02 | Ertel Steven D (SVP & Chief Business Officer) | Sale | 10,000 | 26.43 | 264,350 |
| 2014-09-02 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 10,000 | 2.74 | 27,400 |
| 2014-08-25 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 9,000 | 3.88 | 34,920 |
| 2014-08-18 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 2,500 | 29.77 | 74,412 |
| 2014-08-14 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 9,000 | 29.93 | 269,325 |
| 2014-08-14 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 5,000 | 5.88 | 29,400 |
| 2014-08-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 13,000 | 29.91 | 388,765 |
| 2014-08-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 13,000 | 3.83 | 49,751 |
| 2014-08-14 | Ertel Steven D (SVP & Chief Business Officer) | Sale | 10,000 | 29.97 | 299,730 |
| 2014-08-14 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 10,000 | 2.74 | 27,400 |
| 2014-08-14 | Knopf John L (CEO and President) | Sale | 17,500 | 29.78 | 521,150 |
| 2014-08-14 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 7,500 | 29.95 | 224,602 |
| 2014-08-14 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 6,000 | 1.14 | 6,839 |
| 2014-08-14 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 10,000 | 29.77 | 297,750 |
| 2014-08-14 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 10,000 | 3.88 | 38,800 |
| 2014-08-12 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 8,000 | 1.80 | 14,400 |
| 2014-07-30 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 8,000 | 3.88 | 31,040 |
| 2014-07-23 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 10,000 | 1.80 | 18,000 |
| 2014-07-18 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 2,500 | 26.22 | 65,557 |
| 2014-07-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 5,000 | 29.51 | 147,550 |
| 2014-07-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 5,000 | 3.10 | 15,500 |
| 2014-07-09 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 7,500 | 29.04 | 217,815 |
| 2014-07-09 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 6,000 | .48 | 2,880 |
| 2014-07-07 | Knopf John L (CEO and President) | Sale | 17,500 | 32.02 | 560,402 |
| 2014-07-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 10,000 | 31.99 | 319,930 |
| 2014-07-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 10,000 | 3.88 | 38,800 |
| 2014-07-01 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 2,000 | 34.10 | 68,200 |
| 2014-07-01 | Ertel Steven D (SVP & Chief Business Officer) | Sale | 10,000 | 34.09 | 340,950 |
| 2014-07-01 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 10,000 | 2.74 | 27,400 |
| 2014-06-30 | Maniatis Tom | Sale | 41,000 | 34.14 | 1,399,740 |
| 2014-06-26 | George Jean (Director) | Sale | 10,320 | 35.01 | 361,303 |
| 2014-06-25 | George Jean (Director) | Sale | 171 | 35.00 | 5,985 |
| 2014-06-24 | George Jean (Director) | Sale | 10,402 | 35.03 | 364,382 |
| 2014-06-23 | George Jean (Director) | Sale | 13,618 | 35.27 | 480,306 |
| 2014-06-20 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 7,000 | 35.00 | 245,000 |
| 2014-06-20 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 5,000 | 5.88 | 29,400 |
| 2014-06-20 | George Jean (Director) | Sale | 1,457 | 35.02 | 51,024 |
| 2014-06-18 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 2,500 | 34.31 | 85,775 |
| 2014-06-17 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 8,000 | 3.88 | 31,040 |
| 2014-06-13 | Quisel John D (VP General Counsel & Secretary) | Sale | 9,000 | 33.99 | 305,955 |
| 2014-06-13 | Quisel John D (VP General Counsel & Secretary) | Option Ex | 9,000 | 3.36 | 30,240 |
| 2014-06-11 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 7,500 | 33.24 | 249,300 |
| 2014-06-11 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 6,000 | .48 | 2,880 |
| 2014-06-09 | Knopf John L (CEO and President) | Sale | 15,000 | 31.57 | 473,625 |
| 2014-06-09 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 10,000 | 31.58 | 315,780 |
| 2014-06-09 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 10,000 | 3.88 | 38,800 |
| 2014-06-02 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 2,000 | 29.72 | 59,440 |
| 2014-06-02 | Ertel Steven D (SVP & Chief Business Officer) | Sale | 10,000 | 29.83 | 298,270 |
| 2014-06-02 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 10,000 | 2.74 | 27,400 |
| 2014-05-28 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 7,500 | 30.98 | 232,350 |
| 2014-05-28 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 6,000 | .48 | 2,880 |
| 2014-05-19 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 9,000 | 31.79 | 286,065 |
| 2014-05-19 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 5,000 | 5.88 | 29,400 |
| 2014-05-19 | Quisel John D (VP General Counsel & Secretary) | Sale | 9,000 | 31.66 | 284,940 |
| 2014-05-19 | Quisel John D (VP General Counsel & Secretary) | Option Ex | 9,000 | 2.40 | 21,600 |
| 2014-05-19 | Ertel Steven D (SVP & Chief Business Officer) | Sale | 10,000 | 31.88 | 318,780 |
| 2014-05-19 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 10,000 | 2.74 | 27,400 |
| 2014-05-19 | Knopf John L (CEO and President) | Sale | 15,000 | 31.86 | 477,855 |
| 2014-05-19 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 2,500 | 31.79 | 79,482 |
| 2014-05-19 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 10,000 | 31.85 | 318,530 |
| 2014-05-19 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 10,000 | 3.88 | 38,800 |
Insider trading activities including stock purchases, stock sales, and option exercises
of XLRN listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Acceleron Pharma Inc (symbol XLRN,
CIK number 1280600) see
the Securities and Exchange Commission (SEC) website.